About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of Evacetrapib and Digoxin in Healthy Participants

NCT01897493·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Eli Lilly and Company

Age

18–65

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Overtly healthy males and females (of non-childbearing potential)
Have a body mass index of 18 to 32 kilograms per square meter (kg/m\^2)
Normal renal function

You may not be if

Participants who currently smoke or use tobacco or nicotine products

The record

StatusCompleted

PhasePhase 1

Taking part16

StartedJul 2013

UpdatedOct 9, 2018

Conditions

Healthy Volunteers

Where1

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Dallas, Texas, United States

Clareo Health | A Study of Evacetrapib and Digoxin in Healthy Participants